The DHS Program User Forum
Discussions regarding The DHS Program data and results
Home » Topics » Service Provision Assessment (SPA) » Bangladesh Health Facility Survey 2017 (Availability of Tetanus toxoid vaccine and injectable insulin at health facilities in Bangladesh)
Bangladesh Health Facility Survey 2017 [message #21988] Wed, 13 January 2021 13:02 Go to next message
shakim is currently offline  shakim
Messages: 2
Registered: January 2021
Dear Bridgette and SPA experts,

I am working with Bangladesh Health Facility Survey (BHFS), 2017. I used variable Q1422(5) and Q906(08) for creating "tetanus toxoid vaccine" as a medicine for ANC service in Nepal Health Facility Survey, 2015 and Afghanistan SPA and the percentage was similar to the reports.
Variable Q1422(5) is not available in BHFS 2017, though Q906(08) is available. If I use only Q906(08) for the variable "tetanus vaccine" as a medicine for ANC service in BHFS 2017, would it be correct?
If not, please help in identifying the variable "tetanus toxoid vaccine" for ANC service using BHFS 2017.

Another issue:
I created variable "Injectable glucose solution" as a medicine for diabetes using Q903(15), the percentage (19.2) is similar to the report (page 152, table 8.2). Similarly, I created variable "Injectable insulin" using Q903(18), but the percentage was not similar to the report which is 29.2. Please help in creating the variable "Injectable insulin" in BHFS 2017.

Thanks for your attention.
Re: Bangladesh Health Facility Survey 2017 [message #22009 is a reply to message #21988] Tue, 19 January 2021 09:52 Go to previous message
Bridgette-DHS is currently offline  Bridgette-DHS
Messages: 2280
Registered: February 2013
Senior Member

Following is a response from SPA Survey Specialist, Rajendra Dangol:

In 2017 BHFS, the TT vaccine information for maternal services can be found in Q1022 (01) and Q1027 (01) where the TT vaccine usually kept with other vaccines in a common vaccination area.

The specification used for the "Injectable glucose solution" variable is Q903(15)=GLUCOSE INJECTABLE SOLUTION should be matching with the report results. However, you used Q903(18)=INSULIN INJECTIONS [ANTI DIABETIC]. Please use Q903(15) instead of Q903(18).

The Specification used for variable "Injectable insulin" should be Q903 (18) as mentioned earlier; there were different variables (other than Q903 (18)) that were included in the definition of "Injectable insulin" in the report that lead to the difference; we are currently reviewing these variables but you can use only Q903 (18) for this indicator.

Previous Topic: Medicine Availability for routine antenatal care in Bangladesh
Next Topic: Replicating table 6.4 and 6.6 of Bangladesh SPA 2017
Goto Forum:

Current Time: Mon May 17 21:40:05 Coordinated Universal Time 2021